
Am J Psychiatry 159:983-990, June 2002
© 2002 American Psychiatric Association
Historical, Psychopathological, Neurological, and Neuropsychological Aspects of Deficit Schizophrenia: A Multicenter Study
Silvana Galderisi, M.D., Ph.D.,
Mario Maj, M.D., Ph.D.,
Armida Mucci, M.D., Ph.D.,
Giovanni Battista Cassano, M.D.,
Giordano Invernizzi, M.D.,
Alessandro Rossi, M.D.,
Antonio Vita, M.D.,
Liliana DellOsso, M.D.,
Enrico Daneluzzo, M.D., and
Stefano Pini, M.D., Ph.D.
OBJECTIVE: This multicenter study aimed to verify whether the historical and psychopathological characteristics of a large group of patients with deficit schizophrenia were consistent with those reported in previous studies. The authors also tested the hypothesis that neurological and neuropsychological indices sensitive to frontoparietal dysfunction, but not those sensitive to temporal lobe dysfunction, are more impaired in patients with deficit schizophrenia than in those with nondeficit schizophrenia. METHOD: For each patient with deficit schizophrenia enrolled in the study, a matched subject with nondeficit schizophrenia was recruited. Historical, psychopathological, neurological, and neuropsychological evaluations were carried out for all patients. RESULTS: Patients with deficit schizophrenia, compared with patients with nondeficit schizophrenia, had a similar severity of positive symptoms and disorganization and less hostility. They had poorer premorbid adjustment during childhood and early adolescence and exhibited more impairment in general cognitive abilities. The deficit state was associated with impairment in sequencing of complex motor acts, which suggests frontoparietal dysfunction. CONCLUSIONS: Previous reports of differences in historical, psychopathological, and neuropsychological characteristics between patients with deficit schizophrenia and those with nondeficit schizophrenia were mostly supported by the present findings. Neurological findings suggest that frontoparietal functioning is more impaired in patients with deficit schizophrenia. Deficit schizophrenia might represent a neurodevelopmental subtype of schizophrenia in which significant behavioral and cognitive impairment since childhood compromises the development of basic capacities relevant to subsequent cognitive and social functioning.
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Picchioni and P. Dazzan
Clinical significance of neurological abnormalities in psychosis
Adv. Psychiatr. Treat.,
November 1, 2009;
15(6):
419 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Strauss, D. N. Allen, S. A. Ross, L. A. Duke, and J. Schwartz
Olfactory Hedonic Judgment in Patients With Deficit Syndrome Schizophrenia
Schizophr Bull,
February 17, 2009;
(2009)
sbn178v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Galderisi, M. Quarantelli, U. Volpe, A. Mucci, G. B. Cassano, G. Invernizzi, A. Rossi, A. Vita, S. Pini, P. Cassano, et al.
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia
Schizophr Bull,
March 1, 2008;
34(2):
393 - 401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Cohen, A. M. Saperstein, J. M. Gold, B. Kirkpatrick, W. T. Carpenter Jr, and R. W. Buchanan
Neuropsychology of the Deficit Syndrome: New Data and Meta-analysis of Findings To Date
Schizophr Bull,
September 1, 2007;
33(5):
1201 - 1212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rao, J. R. Spiro, D. J. Schretlen, and N. G. Cascella
Apathy Syndrome After Traumatic Brain Injury Compared With Deficits in Schizophrenia
Psychosomatics,
June 1, 2007;
48(3):
217 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dickinson, M. E. Ramsey, and J. M. Gold
Overlooking the Obvious: A Meta-analytic Comparison of Digit Symbol Coding Tasks and Other Cognitive Measures in Schizophrenia
Arch Gen Psychiatry,
May 1, 2007;
64(5):
532 - 542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Koen, S. Uys, D. J.H. Niehaus, and R. A. Emsley
Negative Symptoms and HIV/AIDS Risk-Behavior Knowledge in Schizophrenia
Psychosomatics,
April 1, 2007;
48(2):
128 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W Buchanan, M. Davis, D. Goff, M. F Green, R. S E Keefe, A. C Leon, K. H Nuechterlein, T. Laughren, R. Levin, E. Stover, et al.
A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia
Schizophr Bull,
January 1, 2005;
31(1):
5 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|